Relation between Development of Nephropathy and the p22phox C242T and Receptor for Advanced Glycation End Product G1704T Gene Polymorphisms in Type 2 Diabetic Patients

Diabetes Care

Volumn 27, Issue 2, 2004, Pages 303-307

  Matsunaga Irie, Seiko ^a   Maruyama, Taro ^b,c   Yamamoto, Yukihiro ^a   Motohashi, Yoshiko ^a   Hirose, Hiroshi ^a   Shimada, Akira ^a   Murata, Mitsuru ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA SOCIAL INSURANCE HOSPITAL   (Japan)

^c NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HEMOGLOBIN A1C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRIACYLGLYCEROL;

ADULT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; JAPAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; P22PHOX C242T GENE; POLYMERASE CHAIN REACTION; RECEPTOR FOR ADVANCED GLYCATION END PRODUCT G1704T GENE; RETROSPECTIVE STUDY; REVIEW; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE OF ONSET; AMINO ACID SUBSTITUTION; BLOOD PRESSURE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NADPH DEHYDROGENASE; NADPH OXIDASE; PHOSPHOPROTEINS; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; RETROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES;

EID: 0842333112     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.2.303     Document Type: Review

References (32)

1. Nishikawa T, Edelstein D, Brownlee M: The missing link: a single unifying mechanism for diabetic complications. Kidney Int 58:S26-S30, 2000
2. Pinizzotto M, Castillo E, Fiaux M, Temler E, Gaillard RC, Ruiz J: Paraoxonase2 polymorphisms are associated with nephropathy in type II diabetes. Diabetologia 44: 104-107, 2001
3. Nomiyama T, Tanaka Y, Piao L, Nagasaka K, Sakai K, Ogihara T, Nakajima K, Watada H, Kawamori R: The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet 48:138-141, 2003
4. Pettersson-Fernholm K, Forsblom C, Hudson BI, Perola M, Grant PJ, Groop PH, Finn-Diane Study Group: The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes 52:891-894, 2003
5. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griedling KK: P22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271:23317-23321, 1996
6. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M: Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 97:135-137, 1998
7. Yamamoto Y, Yamagishi S, Yonekura H, Doi T, Tsuji H, Kato I, Takasawa S, Okamoto H, Abedin J, Tanaka N, Sakurai S, Migita H, Unoki H, Wang H, Zenda T, Wu PS, Segawa Y, Higashide T, Kawasaki K, Yamamoto H: Roles of the AGE-RAGE system in vascular injury in diabetes. Ann N YAcad Sci 902:163-170, 2000
8. Kankova K, Zahejsky J, Marova I, Muzik J, Kuhrova V, Blazkova M, Znojil V, Beranek M, Vacha J: Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM. J Diabetes Complications 15:185-192, 2001
9. Kankova K, Marova I, Zahejsky J, Muzik J, Stejskalova A, Znojil V, Vacha J: Polymorphisms 1704G/T and 2184A/G in the RAGE gene are associated with antioxidant status. Metabolism 50:1152-1160, 2001.
10. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM, Wautier JL: Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol 280:E685-E694, 2001
11. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
12. Blin N, Stafford DW: A general method for isolation of high molecular weight DNA from eukaryocytes. Nucleic Acid Res 3:2303-2308, 1976
13. Whitcombe D, Brownie J, Gillard HL, McKechnie D, Theaker J, Newton CR, Littie S: A homogeneous fluorescence assay for PCR amplicons: its application to real-time, single-tube genotyping. Clin Chem 44:918-923, 1998
14. Guzik TJ, West NE, Black E, McDonald D, Ramatunga C, Pillai R, Channon KM: Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 102:1744-1747, 2000
15. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM: Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxidase synthase. Circulation 105:1656-1662, 2002
16. Dinauer MC, Pierce EA, Bruns GA, Curnutte JT, Orkin SH: Human neutrophil cytochrome b light chain (p22-phox): gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 86:1729-1737, 1990
17. Wolin MS: How could a genetic variant of the p22 phox component of NAD(P)H oxidases contribute to the progression of coronary atherosclerosis? Circ Res 86: 365-366, 2000
18. Gardemann A, Mages P, Katz N, Tillmanns H, Haberbosch W: The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 145:315-323, 1999
19. Cahilly C, Ballantyne CM, Lim DS, Gotto A, Marian AJ: A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 86:391-395, 2000
20. Ito D, Murata M, Watanabe K, Yoshida T, Saito I, Tanahashi N, Fukuuchi Y: C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 31:936-939, 2000
21. Stanger O, Renner W, Khoschsorur G, Rigler B, Wascher TC: NADH/NADPH oxidase p22phox C242T polymorphism and lipid peroxidation in coronary artery disease. Clin Physiol 21:718-722, 2001
22. Cai H, Duarte N, Wilcken DE, Wang XL: NADH/NADPH oxidase p22 phox C242T polymorphism and coronary artery disease in the Australian population. Eur J Clin Invest 29:744-748, 1999
23. Hayaishi-Okano R, Yamasaki Y, Kajimoto Y, Sakamoto K, Ohtoshi K, Katakami N, Kawamori D, Miyatsuka T, Hatazaki M, Hazama Y, Hon M: Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care 26:458-463, 2003
24. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004, 1992
25. Soulis T, Cooper ME, Vranes D, Bucala R, Jerums G: Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment. Kidney Int 50:627-634, 1996
26. Nakamura S, Makita Z, Ishikawa S, Yasumura K, Fujii W, Yanagisawa K, Kawata T, Koike T: Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes 46:895-899, 1997
27. Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanabe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, Yamamoto H: Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest 108:261-268, 2001
28. Heidland A, Sebekova K, Schinzel R: Advanced glycation end products and the progressive course of renal disease. Am J Kidney Dis 38:S100-S106, 2001
29. Parving HH, Chaturvedi N, Viberti G, Mogensen CE: Does microalbuminuria predict diabetic nephropathy? Diabetes Care 25:406-407, 2002
30. Nishimura M, Sasaki T, Ohishi A, Oishi M, Kono S, Totani Y, Kato Y, Noto Y, Misaki S, Higashi K, Shimada F, Wakasugi H, Inoue K, Hoshiyama Y, Yamada K: Angiotensin-converting enzyme inhibitors and probucol suppress the time-dependent increase in urinary type IV collagen excretion of type II diabetes mellitus patients with early diabetic nephropathy. Clin Nephrol 56:96-103, 2001
31. Bursell SE, King GL: Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications? Diabetes Res Clin Pract 45:169-182, 1999
32. Morcos M, Borcea V, Isermann B, Gehrke S, Ehret T, Henkels M, Schiekofer S, Hofmann M, Amiral J, Tritschler H, Ziegler R, Wahl P, Nawroth PP: Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract 52:175-183, 2001